# A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease

> **NCT01448850** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 464 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **BIOLOGICAL:** MEDI8968 600 mg IV, 300 mg SC
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01448850
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 464 (ACTUAL)
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448850, "A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01448850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*